Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 206211
Company: MISSION PHARMACAL
Company: MISSION PHARMACAL
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| POTASSIUM IODIDE | POTASSIUM IODIDE | 65MG/ML | SOLUTION;ORAL | Over-the-counter | None | No | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 03/24/2016 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
POTASSIUM IODIDE
The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.
SOLUTION;ORAL; 65MG/ML
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | Application No. | Company |
|---|---|---|---|---|---|---|---|
| POTASSIUM IODIDE | POTASSIUM IODIDE | 65MG/ML | SOLUTION;ORAL | Over-the-counter | No | 206211 | MISSION PHARMACAL |